Literature DB >> 8215726

Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care.

M M Ward1, J P Leigh, J F Fries.   

Abstract

BACKGROUND: To determine whether patients with rheumatoid arthritis and their physicians make appropriate decisions regarding referral to rheumatologists and the need for continuing rheumatology care, we examined the relationship between the progression of functional disability in these patients and their use of rheumatology subspecialty care over time.
METHODS: A cohort of 282 patients with rheumatoid arthritis was followed prospectively for up to 10 years. Participants were categorized into three subgroups based on the pattern of care received from rheumatologists over the study period: patients who were never treated by a rheumatologist; patients treated by a rheumatologist only intermittently; and patients treated by a rheumatologist at least once during each 6-month study period. The outcome was the rate of progression of functional disability, measured using the Health Assessment Questionnaire Disability Index.
RESULTS: Among the 52 patients who had not been referred to a rheumatologist, 30 (58%) had rates of progression of functional disability that were stable or improving over time (rate < 0.01 Disability Index units per year), while 22 (42%) had rates that were worsening (rate > or = 0.01 Disability Index units per year). Among patients treated by rheumatologists, the average rate of progression was substantially lower among the 69 patients who were treated regularly by a rheumatologist than among 161 patients treated by rheumatologists intermittently (0.008 Disability Index units per year vs 0.020 Disability Index units per year). This difference was associated with more intensive use of second-line antirheumatic medications, and more frequent joint surgeries, among patients treated by rheumatologists on a regular basis.
CONCLUSIONS: Most patients with rheumatoid arthritis in this community cohort were treated by a rheumatologist, but 42% of those not referred had progressively increasing functional disability. Among patients treated by rheumatologists, those who had continuing care from rheumatologists experienced lower rates of progression of functional disability than those who had only intermittent care. These results suggest that use of rheumatology subspecialty care is associated with better health outcomes in rheumatoid arthritis.

Entities:  

Mesh:

Year:  1993        PMID: 8215726

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

Review 1.  The good (gatekeeper), the bad (gatekeeper), and the ugly (situation)

Authors:  C Laine; B J Turner
Journal:  J Gen Intern Med       Date:  1999-05       Impact factor: 5.128

2.  Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus.

Authors:  Chris Tonner; Laura Trupin; Jinoos Yazdany; Lindsey Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

3.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

4.  A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.

Authors:  G Bendix; A Bjelle
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

Review 5.  [What is certain in the treatment of rheumatoid arthritis?]

Authors:  Torsten Witte
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

6.  Medicaid and access to care among persons with systemic lupus erythematosus.

Authors:  JoAnn Zell Gillis; Jinoos Yazdany; Laura Trupin; Laura Julian; Pantelis Panopalis; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

7.  Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; JoAnn Zell Gillis; Laura Trupin; Patricia Katz; Pantelis Panopalis; Lindsey A Criswell; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

8.  Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT Investigators.

Authors:  R S Phillips; M B Hamel; J M Teno; P Bellamy; S K Broste; R M Califf; H Vidaillet; R B Davis; L H Muhlbaier; A F Connors
Journal:  J Gen Intern Med       Date:  1996-07       Impact factor: 5.128

Review 9.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

10.  Management of the early and late presentations of rheumatoid arthritis: a survey of Ontario primary care physicians.

Authors:  R H Glazier; D M Dalby; E M Badley; G A Hawker; M J Bell; R Buchbinder; S C Lineker
Journal:  CMAJ       Date:  1996-09-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.